In a recent series of cases, the Court of Appeals for the Federal Circuit (CAFC) evaluated whether examples in a patent specification will support infringement of alternative embodiments. Two recent ...

The Recentive decision exemplifies the Federal Circuit’s skepticism toward claims that dress up longstanding business problems in machine-learning garb, while the USPTO’s examples confirm that ...

The Federal Circuit Court of Appeals affirmed the Patent Trial and Appeal Board's determination that a patent specification did not provide written description support for range limitations in the ...

“Though these new guidelines may seem unnecessary, there is clear benefit to the public, especially to the applicants who rely on patents for future innovative endeavors.” The United States Patent and ...

This is the second installment in a two-part series examining the implications of using generative artificial intelligence (GAI) in the drafting ...

Exploring the state of pharma patents following the Supreme Court’s Amgen v. Sanofi decision. Lee (Harness IP): This is actually a huge-stakes case because this case discusses one of the most ...

Early this spring, in Hoffmann-La Roche, Inc. v. Promega, the United States Court of Appeals for the Federal Circuit reviewed a district court opinion on the validity of an issued patent 1. The court ...

Is it possible to patent biotech and pharmaceutical inventions globally using just one specification? John T Callahan and Ken Sakurabayashi of Sughrue Mion PLLC examine practice in the US, Japan and ...

Aparna Kareer and Sneha Agarwal of Obhan & Associates discuss the provisions of Indian patent law under which experimental data is required, the nature of the data and submission stages Experimental ...

The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP. Recently, all eyes have ...